世界の植込み型除細動器市場2023-2030:製品種類別(経静脈植込み型除細動器)、タイプ別、NYHAクラス別、エンドユーザー別、地域別

【英語タイトル】Implantable Cardioverter Defibrillator Market Size, Share & Trends Analysis Report By Product Type (Transvenous Implantable Cardioverter-Defibrillators), By Type, By NYHA Class, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料(GRV23NOV144)・商品コード:GRV23NOV144
・発行会社(調査会社):Grand View Research
・発行日:2023年9月
・ページ数:174
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,360,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

植込み型除細動器市場の成長と動向
Grand View Research社の最新レポートによると、植込み型除細動器の世界市場規模は2030年までに59億米ドルに達すると予測されています。2023年から2030年までの年平均成長率は6.4%と予測されています。この成長は、製品技術の進歩、突然の心停止の有病率の増加、心臓の健康に関する一般市民の意識の高まり、政府や医療機関による支援政策など、さまざまな要因によるものです。これらの要因が総体的に除細動器需要を促進し、市場全体の拡大に寄与しています。

心臓再同期療法装置(CRT-D)および植込み型除細動器(ICD)の世界的な需要は、心血管疾患やその他の心臓疾患の有病率の増加によって促進されています。突然の心停止(SCA)は依然として重大な死亡原因であり、発生率と関連する危険因子が増加しています。心不全は世界的な健康問題に大きく寄与しており、CRT-D や除細動器の必要性を高めています。さらに、特に高齢者や冠動脈疾患(CAD)患者における異常な心臓リズムの蔓延が、ICDの需要をさらに押し上げています。CRT-DやICDは、心血管疾患の治療や患者の予後改善において重要性を増しています。

ICD市場はCOVID-19の大流行によりマイナスの影響を受けました。2020年第1四半期は、選択的手術の中止とCOVID-19患者への集中治療が市場に影響を与えました。しかし、パンデミックは不整脈患者の遠隔監視を含むテレヘルスの採用を加速させました。心臓リズム学会が発表したガイドラインでは、対面診療の制限と遠隔診療の促進が強調されています。ビオトロニックは、在宅モニタリング技術を搭載した植え込み型CRMデバイスを宣伝することで、この傾向を利用しました。心血管系遠隔モニタリングの成長にもかかわらず、一部のEU諸国を含む特定の地域では償還が制限されており、市場全体の拡大を妨げています。約13の調査対象国では、心不全管理に関する遠隔技術の償還がまだ行われていません。

植込み型除細動器市場レポートハイライト

- 製品タイプ別では、経静脈植込み型除細動器(T-ICD)分野が2022年に89.94%の最大売上シェアを獲得しました。これは、T-ICDが生命を脅かす心室性不整脈を管理し、侵襲的な手術に伴う手技合併症や医療費を削減するという貴重な利点を提供するためです。

- タイプ別では、両心室デバイスセグメントが2022年に44.60%の最大売上シェアを占めました。これは、心臓突然死の有病率の増加、ペースメーカーおよび除細動器としての機能によるもので、CRT-Dデバイスの需要を牽引すると期待されています。

- NYHA分類に基づくと、NYHA分類II心不全患者の治療における関連性と有効性により、NYHA分類IIセグメントが2022年に67.57%の最大の売上シェアを占めました。NYHAクラスIIの患者は症状が軽く、身体活動時の制限もないため、ICDデバイスの候補に適しています。

- 最終用途別では、病院セグメントが2022年に86.55%の最大売上シェアを獲得しました。このセグメントの急成長は、病院が患者に優れたケアを提供し、医療処置に好んで選択されるなど、いくつかの要因によるものです。心血管疾患患者の増加が予測される中、病院は除細動器の移植で有利な成長を遂げることが期待されています。

- 地域別では、北米地域が2022年に41.7%を超える最大の収益シェアで市場を支配しました。北米は、病院、診療所、医療施設などの高度な医療インフラが発達しています。さらに、この地域は高血圧を含む心血管疾患(CVD)の有病率も高く、ICDの使用が必要となっています。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 世界の植込み型除細動器市場変数・傾向・範囲
第4章 世界の植込み型除細動器市場:製品別分析
第5章 世界の植込み型除細動器市場:種類別分析
第6章 世界の植込み型除細動器市場:NYHAクラス別分析
第7章 世界の植込み型除細動器市場:エンドユーザー別分析
第8章 世界の植込み型除細動器市場:地域別分析
第9章 競合分析

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation
1.1.1 Segment Definitions
1.1.1.1 Product Type Segment
1.1.1.2 Type Segment
1.1.1.3 Nyha Class Segment
1.1.1.4 End-Use Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective – 1
1.4.2 Objective – 2
1.4.3 Objective – 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.9.1.1 Research Scope and Assumptions
1.10 List of Secondary Sources
1.11 List of Primary Sources
1.12 List of Abbreviations
Chapter 2. Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot-1
2.3 Segment Snapshot – 2
2.4 Competitive Landscape
Chapter 3. Implantable Cardioverter Defibrillators Market Variables and Trends
3.1 Implantable Cardioverter Defibrillators (ICD) Market Lineage Outlook
3.1.1 Parent Market Outlook – Cardiac Rhythm Management Devices Market
3.1.2 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Increasing Prevalence of Cardiovascular Diseases & Other Heart Ailments
3.2.1.2 Growing Technological & Product Development Activities
3.2.1.3 Recognition of Subcutaneous ICDs
3.2.2 Market Restraint Analysis
3.2.2.1 Product Recalls
3.2.2.2 Gender & Regional Implantation Disparity and Cybersecurity Concerns
3.3 Regulatory Framework
3.3.1 Standards And Compliances
3.3.1.1 North America
3.3.1.2 Europe
3.3.1.3 Asia Pacific (APAC)
3.3.1.4 Latin America (LATAM)
3.3.1.5 Middle East & Africa (MEA)
3.3.2 Reimbursement Scenario
3.3.2.1 U.S.
3.3.2.2 Canada
3.3.2.3 Germany
3.3.2.4 UK
3.3.2.5 Japan
3.3.2.6 Australia
3.3.2.7 China
3.4 Impact of COVID-19 Pandemic
3.5 Volume of ICD Patients Suffering Heart Failure
3.6 Percentage of ICD Patients Undergoing Battery Change and Complication Rate
3.6.1 Percentage Of Icd Patients Undergoing Battery Change
3.6.2 Complication Rate
3.7 Assessment of Trials On ICD Therapies
3.7.1 Multisite Stimulation In Cardiomyopathy (Mustic) Trial
3.7.2 Multicenter Insync Randomized Clinical Evaluations (Miracle) Trial
3.7.3 Comparison Of Medical Therapy, Pacing, And Defibrillation In Hf (Companion) Trial
3.7.4 Cardiac Resynchronization-Hf (Care-Hf) Trial
3.7.5 Multicenter Automative Defibrillator Implantation With Cardiac Resynchronization Therapy (Madit-Crt) Trial
3.7.6 The Danish Study To Assess The Efficacy Of Implantable Cardioverter Defibrillators In Patients Suffering From Nonischemic Systolic Heart Failure Mortality (Danish) Trial
3.7.7 British Trial
3.8 Industry Analysis Tools
3.8.1 Porter’s Analysis
3.8.2 Macroeconomic Analysis
Chapter 4. Implantable Cardioverter Defibrillators Market: Product Type Analysis
4.1 Product Type Movement Analysis & Market Share, 2022 & 2030
4.2 Implantable Cardioverter Defibrillators Market Estimates & Forecast, By Product Type (USD Million)
4.3 Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
4.3.1 Transvenous Implantable Cardioverter Defibrillators Market, 2018 – 2030 (USD Million)
4.4 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
4.4.1 Subcutaneous Implantable Cardioverter Defibrillators Market, 2018 – 2030 (USD Million)
Chapter 5. Implantable Cardioverter Defibrillators Market: Type Analysis
5.1 Type Movement Analysis & Market Share, 2022 & 2030
5.2 Implantable Cardioverter Defibrillators Market Estimates & Forecast, By Type (USD Million)
5.3 Single Chamber ICDs
5.3.1 Common Conditions in Patients Using Single-Chamber ICDs
5.3.2 Single Chamber ICDS Market, 2018 – 2030 (USD Million)
5.4 Dual Chamber ICDs
5.4.1 Common Conditions in Patients Using Dual-Chamber ICDs
5.4.2 Dual Chamber ICDS Market, 2018 – 2030 (USD Million)
5.5 Biventricular Devices
5.5.1 Biventricular Devices Market, 2018 – 2030 (USD Million)
Chapter 6. Implantable Cardioverter Defibrillators Market: NYHA Class Analysis
6.1 NYHA Class Movement Analysis & Market Share, 2022 & 2030
6.2 Implantable Cardioverter Defibrillators Market Estimates & Forecast, By NYHA Class (USD Million)
6.3 NYHA Class II
6.3.1 NYHA Class II Market, 2018 – 2030 (USD Million)
6.4 NYHA Class III
6.4.1 NYHA Class III Market, 2018 – 2030 (USD Million)
Chapter 7. Implantable Cardioverter Defibrillators Market: End-use Analysis
7.1 End-use Movement Analysis & Market Share, 2022 & 2030
7.2 Implantable Cardioverter Defibrillators Market Estimates & Forecast, By End-use (USD Million)
7.3 Hospitals
7.3.1 Variation of ICD Implants as Per the Type of Hospitals
7.3.2 Hospitals Market, 2018 – 2030 (USD Million)
7.4 Ambulatory Surgical Centers
7.4.1 Ambulatory Surgical Centers Market, 2018 – 2030 (USD Million)
7.5 Others
7.5.1 Others Market, 2018 – 2030 (USD Million)
Chapter 8. Implantable Cardioverter Defibrillators Market: Regional Estimates & Trend Analysis
8.1 Implantable Cardioverter Defibrillators Market: Regional Outlook
8.2 North America
8.2.1 North America Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 U.S. Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Technology Used By Vendors For Patient Monitoring In Canada
8.2.3.3 Canada Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3 Europe
8.3.1 Europe Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.2 Uk
8.3.2.1 Key Country Dynamics
8.3.2.2 Hypertension Cases In Uk
8.3.2.3 Uk Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Key Country Dynamics
8.3.3.2 Germany Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 France Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Causes Of Replacement According To Indication
8.3.5.3 Italy Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Spain Implantable Cardioverter Defibrillators Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Denmark Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Sweden Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Norway Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Japan Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 China Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 India Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Key Country Dynamics
8.4.5.2 Australia Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.6 South Korea
8.4.6.1 Key Country Dynamics
8.4.6.2 South Korea Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.7 Thailand
8.4.7.1 Key Country Dynamics
8.4.7.2 Thailand Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Brazil Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Mexico Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Argentina Implantable Cardioverter Defibrillators Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 MEA Implantable Cardioverter Defibrillators Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.6.3 South Africa
8.6.3.1 Key Country Dynamics
8.6.3.2 South Africa Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6.4 Saudi Arabia
8.6.4.1 Key Country Dynamics
8.6.4.2 Saudi Arabia Implantable Cardioverter Defibrillators Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.6.5 UAE
8.6.5.1 Key Country Dynamics
8.6.5.2 UAE Implantable Cardioverter Defibrillators Market Estimates and Forecasts, 2018 – 2030 (USD Million)
8.6.6 Kuwait
8.6.6.1 Key Country Dynamics
8.6.6.2 Kuwait Implantable Cardioverter Defibrillators Market Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 9. Competitive Analysis
9.1 Company Categorization
9.2 Participants’ Overview
9.3 Financial Performance
9.4 Product Benchmarking
9.5 Company Market Position Analysis
9.5.1 Heat Map Analysis
9.6 SWOT-Analysis
9.6.1 Abbott
9.6.2 Medtronic
9.6.3 Biotronik SE & CO. KG
9.6.4 Boston Scientific Corporation
9.6.5 MicroPort Scientific Corporation
9.6.6 LivaNova PLC
9.7 Company Market Share Analysis, 2022
9.8 Strategy Mapping
9.8.1 Mergers & Acquisitions
9.8.2 Product Launch
9.8.3 Partnerships & Collaborations
9.8.4 Product Approvals
9.8.5 Others

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Volume of ICD patients suffering heart failure
Table 4 Percentage Of ICD Patients Undergoing Battery Change
Table 5 Global Implantable Cardioverter Defibrillators Market Revenue Estimates And Forecast, By Product Type, 2018 - 2030 (USD Million)
Table 6 Global Implantable Cardioverter Defibrillators Market Revenue Estimates And Forecast, By Type, 2018 - 2030 (USD Million)
Table 7 Global Implantable Cardioverter Defibrillators Market Revenue Estimates And Forecast, By NYHA Class, 2018 - 2030 (USD Million)
Table 8 Global Implantable Cardioverter Defibrillators Market Revenue Estimates And Forecast, By End-use, 2018 - 2030 (USD Million)
Table 9 Participant Organizations Involved in The Escape-Net Study-
Table 10 Key Companies Undertaking Mergers & Acquisitions.
Table 11 Key Companies Undertaking Product Launch
Table 12 Key Companies Undergoing Partnerships & Collaborations
Table 13 Key Companies Undergoing Product Approvals
Table 14 Key Companies Undergoing Others

List of Figures

Fig. 1 Implantable Cardioverter Defibrillators Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Information Procurement
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value Chain Based Sizing & Forecasting
Fig. 7 QFD Modelling for Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Market Snapshot
Fig. 10 Segment Snapshot - 1
Fig. 11 Segment Snapshot - 2
Fig. 12 Competitive Landscape
Fig. 13 Cardiac Rhythm Management Devices Market Value, 2022 (USD Billion)
Fig. 14 Implantable Cardioverter Defibrillators Market Dynamics
Fig. 15 Implantable Cardioverter Defibrillators Market: PORTER’s Analysis
Fig. 16 Implantable Cardioverter Defibrillators Market: PESTEL Analysis
Fig. 17 Implantable Cardioverter Defibrillators Market: By Product Type: Key Takeaways
Fig. 18 Implantable Cardioverter Defibrillators Market, By Product Type: Market Share, 2022 & 2030
Fig. 19 Transvenous Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 20 Subcutaneous Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 21 Implantable Cardioverter Defibrillators Market: By Type: Key Takeaways
Fig. 22 Implantable Cardioverter Defibrillators Market, By Type: Market Share, 2022 & 2030
Fig. 23 Common Conditions in Patients Using Single-Chamber ICDs
Fig. 24 Single Chamber ICDs Market, 2018 - 2030 (USD Million)
Fig. 25 Common Conditions in Patients Using Dual-Chamber ICDs
Fig. 26 Dual Chamber ICDs Market, 2018 - 2030 (USD Million)
Fig. 27 Biventricular Devices Market, 2018 - 2030 (USD Million)
Fig. 28 Implantable Cardioverter Defibrillators Market: By NYHA Class: Key Takeaways
Fig. 29 Implantable Cardioverter Defibrillators Market, By NYHA Class: Market Share, 2022 & 2030
Fig. 30 NYHA Class II market, 2018 - 2030 (USD Million)
Fig. 31 NYHA Class III Market, 2018 - 2030 (USD Million)
Fig. 32 Implantable Cardioverter Defibrillators Market, By End-use: Key Takeaways
Fig. 33 Implantable Cardioverter Defibrillators Market, By End-use: Market Share, 2022 & 2030
Fig. 34 Variation of ICD implants as per the type of hospitals
Fig. 35 Hospitals Market, 2018 - 2030 (USD Million)
Fig. 36 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
Fig. 37 Others Market, 2018 - 2030 (USD Million)
Fig. 38 Implantable Cardioverter Defibrillators Market Revenue, By Region, 2022 & 2030, (USD Million)
Fig. 39 Regional Marketplace: Key Takeaways
Fig. 40 Regional Marketplace: Key Takeaways
Fig. 41 North America Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 42 U.S. Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 43 Key Country Dynamics
Fig. 44 Technology Used by Vendors for Patient Monitoring in Canada
Fig. 45 Canada Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 46 Europe Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 47 Key Country Dynamics
Fig. 48 Hypertension Cases In UK (in Million)
Fig. 49 UK Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 50 Key Country Dynamics
Fig. 51 Germany Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 52 Key Country Dynamics
Fig. 53 France Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 54 Key Country Dynamics
Fig. 55 Causes of Replacement According to Indication
Fig. 56 Italy Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 57 Key Country Dynamics
Fig. 58 Spain Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 59 Key Country Dynamics
Fig. 60 Denmark Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 61 Key Country Dynamics
Fig. 62 Sweden Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 63 Key Country Dynamics
Fig. 64 Norway Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 65 Asia Pacific Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 66 Key Country Dynamics
Fig. 67 Japan Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 68 Key Country Dynamics
Fig. 69 China Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 70 Key Country Dynamics
Fig. 71 India Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 72 Key Country Dynamics
Fig. 73 Australia Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 74 Key Country Dynamics
Fig. 75 South Korea Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 76 Key Country Dynamics
Fig. 77 Thailand Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 78 Latin America Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 79 Key Country Dynamics
Fig. 80 Brazil Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 81 Key Country Dynamics
Fig. 82 Mexico Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 83 Key Country Dynamics
Fig. 84 Argentina Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 85 MEA Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 86 Key Country Dynamics
Fig. 87 South Africa Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 88 Key Country Dynamics
Fig. 89 Saudi Arabia Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 90 Key Country Dynamics
Fig. 91 UAE Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 92 Key Country Dynamics
Fig. 93 Kuwait Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
Fig. 94 Key Company Categorization
Fig. 95 Abbott-SWOT analysis
Fig. 96 Medtronic-SWOT analysis
Fig. 97 Biotronik SE & Co. KG -SWOT analysis
Fig. 98 Boston Scientific Corporation-SWOT analysis
Fig. 99 MicroPort Scientific Corporation-SWOT analysis
Fig. 100 LivaNova PLC-SWOT analysis
Fig. 101 Company Market Share Analysis, 2022
Fig. 102 Strategy Mapping

★調査レポート[世界の植込み型除細動器市場2023-2030:製品種類別(経静脈植込み型除細動器)、タイプ別、NYHAクラス別、エンドユーザー別、地域別] (コード:GRV23NOV144)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の植込み型除細動器市場2023-2030:製品種類別(経静脈植込み型除細動器)、タイプ別、NYHAクラス別、エンドユーザー別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆